TOCILIZUMAB

tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices

TOCILIZUMAB (11722Y)

tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices
11722Y
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Active giant cell arteritis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 4 # of repeats: 6 DPMQ: $801.70 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Actemra ACTPen